Subscribe
shutterstock_1524073421_karol_ciesluk
Karol Ciesluk / Shutterstock.com
27 February 2020AmericasSarah Morgan

Vir Biotech partners with WuXi on COVID-19 antibody treatment

Immunology-focused Vir Biotechnology and Hong Kong-based WuXi Biologics have become the latest companies to turn their focus to developing treatments for the novel coronavirus.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

More on this story

Big Pharma
Webinar: antibody patents in Europe and beyond
6 August 2020   Antibody patenting can be a minefield for IP practitioners if they lack the most up-to-date knowledge about the best way to approach a patent application.
Americas
BIO moves 2020 international convention online
6 April 2020   The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
Asia
GSK and Chinese biotech unite for coronavirus vaccine development
25 February 2020   British drugmaker GSK and Chinese biotech Clover Biopharmaceuticals have partnered to develop a protein-based coronavirus vaccine candidate.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB